Cargando…
Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study
Objective: The long-term outcome of children born to SLE mothers still represents a controversial topic in literature, with some studies reporting a possible increased prevalence of different neurologic and psychiatric diseases (NPD), including neurodevelopmental disorders (ND), and in particular le...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772243/ https://www.ncbi.nlm.nih.gov/pubmed/33390998 http://dx.doi.org/10.3389/fphar.2020.613239 |
_version_ | 1783629834830741504 |
---|---|
author | Lazzaroni, Maria-Grazia Andreoli, Laura Crisafulli, Francesca Tamborini, Francesco Debeni, Irene Binda, Valentina Nalli, Cecilia Galli, Jessica Fazzi, Elisa Moroni, Gabriella Franceschini, Franco Tincani, Angela |
author_facet | Lazzaroni, Maria-Grazia Andreoli, Laura Crisafulli, Francesca Tamborini, Francesco Debeni, Irene Binda, Valentina Nalli, Cecilia Galli, Jessica Fazzi, Elisa Moroni, Gabriella Franceschini, Franco Tincani, Angela |
author_sort | Lazzaroni, Maria-Grazia |
collection | PubMed |
description | Objective: The long-term outcome of children born to SLE mothers still represents a controversial topic in literature, with some studies reporting a possible increased prevalence of different neurologic and psychiatric diseases (NPD), including neurodevelopmental disorders (ND), and in particular learning disorders (LD). Different risk factors have been advocated, such as the in utero exposure to auto-antibodies and drugs, particularly Azathioprine (AZA). Methods: A case-control study was designed to compare pregnancies treated with AZA (cases) with those not treated with AZA (controls). All the pregnancies had been prospectively followed in two Italian centers. The match was based upon renal involvement, antiphospholipid (aPL) status, maternal age at pregnancy (±5 years) and child’s age at the time of the study (±2 years). SLE mothers were interviewed by a telephone survey, particularly focused on the presence of a certified NPD in their children ≥6 years of age. Results: Twenty-seven cases and 65 controls were similar in terms of demographic, immunological and clinical features, except for a higher rate of SLE flares during pregnancy in cases (22.2% vs. 10.8%, p:0.191). The 92 children had a mean age of 14.0 years at the time of the survey; 11 had at least one NPD (12.0%). The frequency of each single NPD was similar to that of the general pediatric population and no association was found with either the in utero exposure to AZA, or other specific factors (auto-antibodies, disease activity, obstetric complications, prematurity). Conclusion: The long-term neuropsychiatric outcome of the children born to SLE mothers did not show neither an increased frequency of NPD as compared to the general pediatric population nor a specific pattern of NPD. The in utero exposure to AZA was not associated with the development of NPD in this case-control study of prospectively-followed pregnancies. NPD are complex conditions and large prospective studies are needed to capture the wide range of variables that may contribute to their development in the offspring of SLE women. |
format | Online Article Text |
id | pubmed-7772243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77722432020-12-31 Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study Lazzaroni, Maria-Grazia Andreoli, Laura Crisafulli, Francesca Tamborini, Francesco Debeni, Irene Binda, Valentina Nalli, Cecilia Galli, Jessica Fazzi, Elisa Moroni, Gabriella Franceschini, Franco Tincani, Angela Front Pharmacol Original Research Objective: The long-term outcome of children born to SLE mothers still represents a controversial topic in literature, with some studies reporting a possible increased prevalence of different neurologic and psychiatric diseases (NPD), including neurodevelopmental disorders (ND), and in particular learning disorders (LD). Different risk factors have been advocated, such as the in utero exposure to auto-antibodies and drugs, particularly Azathioprine (AZA). Methods: A case-control study was designed to compare pregnancies treated with AZA (cases) with those not treated with AZA (controls). All the pregnancies had been prospectively followed in two Italian centers. The match was based upon renal involvement, antiphospholipid (aPL) status, maternal age at pregnancy (±5 years) and child’s age at the time of the study (±2 years). SLE mothers were interviewed by a telephone survey, particularly focused on the presence of a certified NPD in their children ≥6 years of age. Results: Twenty-seven cases and 65 controls were similar in terms of demographic, immunological and clinical features, except for a higher rate of SLE flares during pregnancy in cases (22.2% vs. 10.8%, p:0.191). The 92 children had a mean age of 14.0 years at the time of the survey; 11 had at least one NPD (12.0%). The frequency of each single NPD was similar to that of the general pediatric population and no association was found with either the in utero exposure to AZA, or other specific factors (auto-antibodies, disease activity, obstetric complications, prematurity). Conclusion: The long-term neuropsychiatric outcome of the children born to SLE mothers did not show neither an increased frequency of NPD as compared to the general pediatric population nor a specific pattern of NPD. The in utero exposure to AZA was not associated with the development of NPD in this case-control study of prospectively-followed pregnancies. NPD are complex conditions and large prospective studies are needed to capture the wide range of variables that may contribute to their development in the offspring of SLE women. Frontiers Media S.A. 2020-12-16 /pmc/articles/PMC7772243/ /pubmed/33390998 http://dx.doi.org/10.3389/fphar.2020.613239 Text en Copyright © 2020 Lazzaroni, Andreoli, Crisafulli, Tamborini, Debeni, Binda, Nalli, Galli, Fazzi, Moroni, Franceschini and Tincani http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Original Research Lazzaroni, Maria-Grazia Andreoli, Laura Crisafulli, Francesca Tamborini, Francesco Debeni, Irene Binda, Valentina Nalli, Cecilia Galli, Jessica Fazzi, Elisa Moroni, Gabriella Franceschini, Franco Tincani, Angela Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study |
title | Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study |
title_full | Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study |
title_fullStr | Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study |
title_full_unstemmed | Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study |
title_short | Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study |
title_sort | neuropsychiatric outcome of children born to women with systemic lupus erythematosus and exposed in utero to azathioprine: a case-control study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772243/ https://www.ncbi.nlm.nih.gov/pubmed/33390998 http://dx.doi.org/10.3389/fphar.2020.613239 |
work_keys_str_mv | AT lazzaronimariagrazia neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT andreolilaura neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT crisafullifrancesca neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT tamborinifrancesco neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT debeniirene neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT bindavalentina neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT nallicecilia neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT gallijessica neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT fazzielisa neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT moronigabriella neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT franceschinifranco neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT tincaniangela neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy |